The device, called Tap, collects capillary blood for hemoglobin A1c testing, which is commonly used to monitor blood sugar levels in diabetic or pre-diabetic patients, according to a news release.
To draw blood, clinicians position the device on a patient’s upper arm and “with just a ‘tap’, blood is collected,” according to the company’s website.
Seventh Sense Biosystems’ said it’s working with the FDA to offer additional blood testing options, along with an “at home” collection of products.
The Medford, Mass.-based company will launch Tap in the next few months.
More articles on supply chain:
6 must-reads for supply chain leaders this week
UPS to offer Saturday ground delivery services
FDA approves new liquid drug for hypothyroidism
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
